HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 50704,
"recordsTotal": 50704,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&start=48900",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&start=48300",
"results": [
{
"registry_id": "NCT07539441",
"publication_url": "https://clinicaltrials.gov/study/NCT07539441",
"title": "Phase 1/2 Trial of Mirdametinib in Patients With MAPK Pathway Mutant Central Nervous System Tumors",
"has_exemption": false,
"start_date": "2026-04-10",
"completion_date": "2029-10-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07518745",
"publication_url": "https://clinicaltrials.gov/study/NCT07518745",
"title": "Mapping Transcrnial Magnetic Stimulation (TMS) Responses Within the Brain Using Intracranial Electrophysiological Monitoring Recordings",
"has_exemption": false,
"start_date": "2025-11-11",
"completion_date": "2029-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979453",
"publication_url": "https://clinicaltrials.gov/study/NCT06979453",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2029-10-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04908709",
"publication_url": "https://clinicaltrials.gov/study/NCT04908709",
"title": "Spectroscopic MRI Guided Proton Therapy for Pediatric High-Grade Glioma (RAD4500)",
"has_exemption": false,
"start_date": "2018-12-20",
"completion_date": "2029-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07291076",
"publication_url": "https://clinicaltrials.gov/study/NCT07291076",
"title": "ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC)",
"has_exemption": false,
"start_date": "2026-03-16",
"completion_date": "2029-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07365306",
"publication_url": "https://clinicaltrials.gov/study/NCT07365306",
"title": "A Phase 2 Study of Epcoritamab-R-GemOx With Consolidative ASCT and Additional Epcoritamab in Relapsed/Refractory Transplant-Eligible DLBCL",
"has_exemption": false,
"start_date": "2026-07-27",
"completion_date": "2029-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06428409",
"publication_url": "https://clinicaltrials.gov/study/NCT06428409",
"title": "A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers",
"has_exemption": false,
"start_date": "2024-06-20",
"completion_date": "2029-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07549412",
"publication_url": "https://clinicaltrials.gov/study/NCT07549412",
"title": "A Randomized, Open Label, 3-arm Phase 3 Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)",
"has_exemption": false,
"start_date": "2026-05-06",
"completion_date": "2029-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "EMD Serono Research & Development Institute, Inc.",
"sponsor_slug": "emd-serono-research-development-institute-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04094090",
"publication_url": "https://clinicaltrials.gov/study/NCT04094090",
"title": "Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia",
"has_exemption": false,
"start_date": "2019-10-19",
"completion_date": "2029-10-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Goodman Eye Center",
"sponsor_slug": "goodman-eye-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07275216",
"publication_url": "https://clinicaltrials.gov/study/NCT07275216",
"title": "Phase 2 Study of Pembrolizumab With Chemotherapy in Frail Patients With Newly Diagnosed Classical Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07194980",
"publication_url": "https://clinicaltrials.gov/study/NCT07194980",
"title": "Safety and Efficacy of the Addition of Nemtabrutinib to Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2026-10-15",
"completion_date": "2029-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04708041",
"publication_url": "https://clinicaltrials.gov/study/NCT04708041",
"title": "A Phase 3 International, Multicenter, Open-label Study to Evaluate the Safety and Immunogenicity of 9vHPV Vaccine Administered as 2-dose Regimen With Extended Dosing Intervals in 9- to 14-Year Old Boys and Girls Compared With a Standard 3-dose Regimen in 16- to 26-Year Old Women",
"has_exemption": false,
"start_date": "2021-03-15",
"completion_date": "2029-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04144972",
"publication_url": "https://clinicaltrials.gov/study/NCT04144972",
"title": "Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain Using Summit RC+S",
"has_exemption": false,
"start_date": "2019-10-24",
"completion_date": "2029-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05144997",
"publication_url": "https://clinicaltrials.gov/study/NCT05144997",
"title": "LORLATINIB (PF-06463922) CONTINUATION PROTOCOL: AN OPEN-LABEL, SINGLE-ARM CONTINUATION STUDY FOR PARTICIPANTS WITH ALK-POSITIVE OR ROS1-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC) CONTINUING FROM PFIZER SPONSORED LORLATINIB CLINICAL STUDIES",
"has_exemption": false,
"start_date": "2021-12-28",
"completion_date": "2029-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05933577",
"publication_url": "https://clinicaltrials.gov/study/NCT05933577",
"title": "A Phase 3, Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With High-Risk Stage II-IV Melanoma (INTerpath-001)",
"has_exemption": false,
"start_date": "2023-07-19",
"completion_date": "2029-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06704269",
"publication_url": "https://clinicaltrials.gov/study/NCT06704269",
"title": "An Open-label, Multi-center, Phase I/II Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Participants With Treatment-resistant Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2025-04-22",
"completion_date": "2029-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07000357",
"publication_url": "https://clinicaltrials.gov/study/NCT07000357",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event",
"has_exemption": false,
"start_date": "2025-06-04",
"completion_date": "2029-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07543822",
"publication_url": "https://clinicaltrials.gov/study/NCT07543822",
"title": "VATCH (Vascular Anomaly Analysis for Therapy Choice): Phase II Study of Alpelisib Treatment in Subjects With TIE2/PIK3CA Pathway Driven Vascular Anomalies",
"has_exemption": false,
"start_date": "2025-08-27",
"completion_date": "2029-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07549646",
"publication_url": "https://clinicaltrials.gov/study/NCT07549646",
"title": "VATCH (Vascular Anomaly Analysis for Therapy Choice): A Phase II Study of Trametinib Treatment in Subjects With Ras/MAPK Pathway Driven Vascular Anomalies",
"has_exemption": false,
"start_date": "2025-08-27",
"completion_date": "2029-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07767474",
"publication_url": "https://clinicaltrials.gov/study/NCT07767474",
"title": "First-in-human Study of ATX-898, as Monotherapy and in Combination With Other Anti-neoplastic Agents, in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Antares Therapeutics, Inc",
"sponsor_slug": "antares-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07773727",
"publication_url": "https://clinicaltrials.gov/study/NCT07773727",
"title": "A Phase 2, Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of ARGX-121 SC in Adult Participants With Primary IgA Nephropathy",
"has_exemption": false,
"start_date": "2026-10-15",
"completion_date": "2029-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04419649",
"publication_url": "https://clinicaltrials.gov/study/NCT04419649",
"title": "A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)",
"has_exemption": false,
"start_date": "2020-08-19",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05187338",
"publication_url": "https://clinicaltrials.gov/study/NCT05187338",
"title": "Triplex CTLA4/PD1/PDL1 Checkpoint Inhibitors Combination Therapy for Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2021-11-01",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06513962",
"publication_url": "https://clinicaltrials.gov/study/NCT06513962",
"title": "Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07342478",
"publication_url": "https://clinicaltrials.gov/study/NCT07342478",
"title": "A Phase 3 Open-Label, Randomized, Multicenter Study of Rocbrutinib (LP-168) vs Pirtobrutinib in Covalent BTK Inhibitor (cBTKi) Pretreated Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) Subjects",
"has_exemption": false,
"start_date": "2026-04-23",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Newave Pharmaceutical Inc",
"sponsor_slug": "newave-pharmaceutical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07551856",
"publication_url": "https://clinicaltrials.gov/study/NCT07551856",
"title": "Manual Arthroplasty Versus VELYS Robotic-Assisted Solution Functional Alignment Arthroplasty for Knee Osteoarthritis (The MARVEL Project): A Pragmatic, Multicentre, Blinded Randomised Controlled Trial With Multi-domain Investigations",
"has_exemption": false,
"start_date": "2026-07-16",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Golden Jubilee National Hospital",
"sponsor_slug": "golden-jubilee-national-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07412704",
"publication_url": "https://clinicaltrials.gov/study/NCT07412704",
"title": "A Phase 1/2a, Open-label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of BMS-986528 in Participants With Refractory Rheumatoid Arthritis",
"has_exemption": false,
"start_date": "2026-09-15",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00887146",
"publication_url": "https://clinicaltrials.gov/study/NCT00887146",
"title": "Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma",
"has_exemption": false,
"start_date": "2009-09-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04587128",
"publication_url": "https://clinicaltrials.gov/study/NCT04587128",
"title": "Phase II Trial of Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2020-10-19",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04898010",
"publication_url": "https://clinicaltrials.gov/study/NCT04898010",
"title": "Investigator Initiated Pilot Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device (SCD) to Treat ICU Patients With Acute Kidney Injury (AKI) and Hepatorenal Syndrome (HRS) Type I",
"has_exemption": false,
"start_date": "2022-06-09",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lenar Yessayan",
"sponsor_slug": "lenar-yessayan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05894343",
"publication_url": "https://clinicaltrials.gov/study/NCT05894343",
"title": "Long-term Follow-up of Glutamic Acid Decarboxylase Gene Transfer to the Subthalamic Nuclei in Participants With Parkinson's Disease",
"has_exemption": false,
"start_date": "2023-05-19",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "MeiraGTx, LLC",
"sponsor_slug": "meiragtx-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05903092",
"publication_url": "https://clinicaltrials.gov/study/NCT05903092",
"title": "A Phase II Trial of MOnaliZumab in Combination With durvAlumab (MEDI4736) for tReatmenT of Small Cell Lung Cancer (MOZART)",
"has_exemption": false,
"start_date": "2023-09-26",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hirva Mamdani",
"sponsor_slug": "hirva-mamdani",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05800743",
"publication_url": "https://clinicaltrials.gov/study/NCT05800743",
"title": "Evaluation of the GORE® Ascending Stent Graft in the Treatment of Lesions of the Ascending Aorta",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06529731",
"publication_url": "https://clinicaltrials.gov/study/NCT06529731",
"title": "A Phase 2 Trial of Interferon-γ (IFN-γ) in Combination With Donor Leukocyte Infusion (DLI) to Treat Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) After Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)",
"has_exemption": false,
"start_date": "2024-09-23",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sawa Ito, MD",
"sponsor_slug": "sawa-ito-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649539",
"publication_url": "https://clinicaltrials.gov/study/NCT06649539",
"title": "Efficacy of a Step-wise Protocol in Optimizing CCH Outcomes in Men With Peyronie's Disease",
"has_exemption": false,
"start_date": "2024-10-11",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Charitable Union for the Research and Education of Peyronie's Disease",
"sponsor_slug": "charitable-union-for-the-research-and-education-of-peyronies-disease",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06597942",
"publication_url": "https://clinicaltrials.gov/study/NCT06597942",
"title": "Protocol for Maintaining and Improving Mental Status in Alzheimer's Disease (PROMIS-AD): a Pilot Study of Large-Coil Parietal Repetitive Transcranial Magnetic Stimulation for Alzheimer&Amp;Amp;#39;s Disease",
"has_exemption": false,
"start_date": "2024-10-17",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06619561",
"publication_url": "https://clinicaltrials.gov/study/NCT06619561",
"title": "A Phase 2, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, PK, and Efficacy of Vimseltinib in Adults With Active Chronic GVHD After Failure of Prior Systemic Therapy",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Deciphera Pharmaceuticals LLC",
"sponsor_slug": "deciphera-pharmaceuticals-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06558214",
"publication_url": "https://clinicaltrials.gov/study/NCT06558214",
"title": "OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial",
"has_exemption": false,
"start_date": "2024-12-10",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06789445",
"publication_url": "https://clinicaltrials.gov/study/NCT06789445",
"title": "A Phase 1/2a Study of Subretinal Administration of OpCT-001 Photoreceptor Precursor Cells Derived From iPSCs in Patients With Primary Photoreceptor Disease",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BlueRock Therapeutics",
"sponsor_slug": "bluerock-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06635889",
"publication_url": "https://clinicaltrials.gov/study/NCT06635889",
"title": "Double-Blind Randomized Placebo Controlled Trial of Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain",
"has_exemption": false,
"start_date": "2025-03-26",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06801834",
"publication_url": "https://clinicaltrials.gov/study/NCT06801834",
"title": "A Global, Multicenter, Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Standard of Care (SOC) in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (ES-SCLC)",
"has_exemption": false,
"start_date": "2025-04-04",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06577714",
"publication_url": "https://clinicaltrials.gov/study/NCT06577714",
"title": "Ablation Guided Via Precision Imaging Using Electromechanical Wave Imaging",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990867",
"publication_url": "https://clinicaltrials.gov/study/NCT06990867",
"title": "Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Phase 2/3 Study to Evaluate the Efficacy and Safety of JX10 in Acute Ischemic Stroke With Late Presentations",
"has_exemption": false,
"start_date": "2025-05-15",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Corxel Pharmaceuticals",
"sponsor_slug": "corxel-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06418178",
"publication_url": "https://clinicaltrials.gov/study/NCT06418178",
"title": "A Dose Optimization Study of MDMA-Assisted Therapy for PTSD in U.S. Veterans",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bronx VA Medical Center",
"sponsor_slug": "bronx-va-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06909565",
"publication_url": "https://clinicaltrials.gov/study/NCT06909565",
"title": "Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07160179",
"publication_url": "https://clinicaltrials.gov/study/NCT07160179",
"title": "Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of ABBV-6628 in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration",
"has_exemption": false,
"start_date": "2025-08-13",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06639282",
"publication_url": "https://clinicaltrials.gov/study/NCT06639282",
"title": "SIPO1-AD: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Siponimod in Patients With Mild Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-08-26",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Joseph's Hospital and Medical Center, Phoenix",
"sponsor_slug": "st-josephs-hospital-and-medical-center-phoenix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06718751",
"publication_url": "https://clinicaltrials.gov/study/NCT06718751",
"title": "Tranexamic Acid Therapy For The Treatment of Subdural Hematomas",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07193550",
"publication_url": "https://clinicaltrials.gov/study/NCT07193550",
"title": "A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218380",
"publication_url": "https://clinicaltrials.gov/study/NCT07218380",
"title": "FORAGER-2: A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Vepugratinib Combined With Enfortumab Vedotin and Pembrolizumab in Adults With Untreated Locally Advanced or Metastatic Urothelial Carcinoma With an FGFR3 Genetic Alteration",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06898970",
"publication_url": "https://clinicaltrials.gov/study/NCT06898970",
"title": "An Open-Label, Multicenter, Phase 2 Study With Safety Lead-In of Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab in Patients With Angiosarcoma",
"has_exemption": false,
"start_date": "2026-01-09",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Varun Monga, MBBS",
"sponsor_slug": "varun-monga-mbbs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06975111",
"publication_url": "https://clinicaltrials.gov/study/NCT06975111",
"title": "Focusing on the Menopausal Transition to Improve Mid-Life Women's Health",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325513",
"publication_url": "https://clinicaltrials.gov/study/NCT07325513",
"title": "Machine Learning in Guiding rTMS Treatment for GWI-Related Headaches and Body Pain",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Veterans Medical Research Foundation",
"sponsor_slug": "veterans-medical-research-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07368985",
"publication_url": "https://clinicaltrials.gov/study/NCT07368985",
"title": "A Phase II Single Arm Open Label Study of Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer: an EMBRACE High Risk Study Initiative",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prof. Dr. Remi A. Nout",
"sponsor_slug": "prof-dr-remi-a-nout",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07175051",
"publication_url": "https://clinicaltrials.gov/study/NCT07175051",
"title": "Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin",
"has_exemption": false,
"start_date": "2026-04-08",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221214",
"publication_url": "https://clinicaltrials.gov/study/NCT07221214",
"title": "GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV - GL1DER HIV RCT",
"has_exemption": false,
"start_date": "2026-04-17",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07419334",
"publication_url": "https://clinicaltrials.gov/study/NCT07419334",
"title": "A Phase 3 Multicenter, Double-Masked, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Efficacy of Gildeuretinol Acetate (ALK 001) on the Progression of Stargardt Disease (STGD)",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alkeus Pharmaceuticals, Inc.",
"sponsor_slug": "alkeus-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07441889",
"publication_url": "https://clinicaltrials.gov/study/NCT07441889",
"title": "Phase I/II Study of Anti-CD3 x Anti-HER2 Bispecific Antibody (HER2Bi) Armed Fresh Peripheral Blood Mononuclear Cells (HER2 FPBMC) in Metastatic Castrate Resistant Prostate Cancer (mCRPC) and Metastatic Breast Cancer (MBC)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07516093",
"publication_url": "https://clinicaltrials.gov/study/NCT07516093",
"title": "A Phase 3, Randomized, Open-label, Multicenter Study of NX-5948 Versus Pirtobrutinib in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)",
"has_exemption": false,
"start_date": "2026-08-03",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nurix Therapeutics, Inc.",
"sponsor_slug": "nurix-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07777822",
"publication_url": "https://clinicaltrials.gov/study/NCT07777822",
"title": "A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib (RMC-9805) as First Line Treatment in Patients With Metastatic Non-squamous RAS G12D-Mutated Non-small Cell Lung Cancer (RASolve 308)",
"has_exemption": false,
"start_date": "2026-08-14",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Revolution Medicines, Inc.",
"sponsor_slug": "revolution-medicines-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07767500",
"publication_url": "https://clinicaltrials.gov/study/NCT07767500",
"title": "A Phase II Single-Arm Study Evaluating Toxicity, Outcomes, and Dosimetry Using an MR-guided Linear Accelerator for the Treatment of Early Stage Kidney Cancer",
"has_exemption": false,
"start_date": "2026-08-19",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07637578",
"publication_url": "https://clinicaltrials.gov/study/NCT07637578",
"title": "A Phase II, Nonrandomized, Single-Arm Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma (CORE-MM)",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SCRI Development Innovations, LLC",
"sponsor_slug": "scri-development-innovations-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07744126",
"publication_url": "https://clinicaltrials.gov/study/NCT07744126",
"title": "A Phase 2 Open-Label Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With Pembrolizumab as First-Line Treatment in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07859813",
"publication_url": "https://clinicaltrials.gov/study/NCT07859813",
"title": "A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ARO-INHBE in Adults With Metabolic Dysfunction-Associated Steatohepatitis With or Without Type 2 Diabetes Mellitus",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Arrowhead Pharmaceuticals",
"sponsor_slug": "arrowhead-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07786428",
"publication_url": "https://clinicaltrials.gov/study/NCT07786428",
"title": "A Phase 2 Randomized Pilot Study to Develop Tailored Neoadjuvant Chemoimmunotherapy Strategies in Stage I Triple-negative Breast Cancer (DETENTE-1)",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07773987",
"publication_url": "https://clinicaltrials.gov/study/NCT07773987",
"title": "Immunotherapy and Nodal-Sparing Irradiation for T-Cell Induction and Unmasking of Tumor Antigenicity in the Microenvironment for Head and Neck Cancer",
"has_exemption": false,
"start_date": "2026-10-08",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07680166",
"publication_url": "https://clinicaltrials.gov/study/NCT07680166",
"title": "An Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations",
"has_exemption": false,
"start_date": "2026-10-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xentria, Inc.",
"sponsor_slug": "xentria-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07788989",
"publication_url": "https://clinicaltrials.gov/study/NCT07788989",
"title": "High-Density Atrial Mapping After Pulsed Field Ablation (PFA): Development of an Algorithm to Predict Atrial Fibrillation (AF) Burden in Participants With Paroxysmal AF (PAF) and Persistent AF (PsAF) Treated With the VARIPULSE™ PFA Catheter",
"has_exemption": false,
"start_date": "2026-10-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biosense Webster, Inc.",
"sponsor_slug": "biosense-webster-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07663487",
"publication_url": "https://clinicaltrials.gov/study/NCT07663487",
"title": "A Prospective, Multicenter, Open-label Two Cohort Study Evaluating the Safety and Efficacy of Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres to Bridge or Downstage Patients With Hepatocellular Carcinoma (HCC) to Liver Transplant or Resection and Elicit Pathologic Necrosis.",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sirtex Medical",
"sponsor_slug": "sirtex-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07878780",
"publication_url": "https://clinicaltrials.gov/study/NCT07878780",
"title": "MRI-based Comparison of OnabotulinumtoxinA (OnabotA) Versus Placebo Injections to the Temporalis and Masseter Muscles in the Management of Myofascial Pain Syndrome: A Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07349641",
"publication_url": "https://clinicaltrials.gov/study/NCT07349641",
"title": "Tirzepatide With Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer in Overweight and Obese Women",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06697496",
"publication_url": "https://clinicaltrials.gov/study/NCT06697496",
"title": "Navigation and Artificial Intelligence Technology for Indigenous Virtual Education on Smoking Cessation (NAITIVE)",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07881458",
"publication_url": "https://clinicaltrials.gov/study/NCT07881458",
"title": "A Phase 3 Study to Investigate the Efficacy and Safety of LY900043 in Adult Participants With Obesity or Overweight and Type 2 Diabetes",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213960",
"publication_url": "https://clinicaltrials.gov/study/NCT07213960",
"title": "A Sequential Phase 2/3, Single-Arm, Open-Label Study in Adults Followed by a Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of APL2 in Adults and Adolescents With Focal Segmental Glomerulosclerosis",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Apellis Pharmaceuticals, Inc.",
"sponsor_slug": "apellis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07881432",
"publication_url": "https://clinicaltrials.gov/study/NCT07881432",
"title": "A Phase 3 Study to Investigate the Efficacy and Safety of LY900043 in Adult Participants With Obesity Without Type 2 Diabetes",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07825402",
"publication_url": "https://clinicaltrials.gov/study/NCT07825402",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P)",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ono Pharmaceutical Co. Ltd",
"sponsor_slug": "ono-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07831577",
"publication_url": "https://clinicaltrials.gov/study/NCT07831577",
"title": "A Randomized, Double-blind, Placebo-controlled, Phase 2/3, Study to Evaluate the Efficacy and Safety of an Intraarticular Injection of GNSC-001 in Participants With Osteoarthritis of the Knee",
"has_exemption": false,
"start_date": "2027-07-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genascence Corporation",
"sponsor_slug": "genascence-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04865939",
"publication_url": "https://clinicaltrials.gov/study/NCT04865939",
"title": "A Randomized Trial Comparing Intravesical Gemcitabine to Continuous Bladder Irrigation With Sterile Water to Prevent Bladder Cancer Implantation in Patients Undergoing Excision of Upper Tract Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2021-11-29",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05538663",
"publication_url": "https://clinicaltrials.gov/study/NCT05538663",
"title": "A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE)",
"has_exemption": false,
"start_date": "2023-02-07",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854003",
"publication_url": "https://clinicaltrials.gov/study/NCT06854003",
"title": "A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2025-04-22",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Christine Ryan",
"sponsor_slug": "christine-ryan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07115940",
"publication_url": "https://clinicaltrials.gov/study/NCT07115940",
"title": "Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well - SELECT LATE Trial",
"has_exemption": false,
"start_date": "2026-04-13",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Amrou Sarraj",
"sponsor_slug": "amrou-sarraj",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07269470",
"publication_url": "https://clinicaltrials.gov/study/NCT07269470",
"title": "Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase",
"has_exemption": false,
"start_date": "2026-07-13",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07715006",
"publication_url": "https://clinicaltrials.gov/study/NCT07715006",
"title": "Dorsal Root Electrical Stimulation to Suppress Spastic Muscle Activation in Children With Cerebral Palsy",
"has_exemption": false,
"start_date": "2026-07-16",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Martin Piazza",
"sponsor_slug": "martin-piazza",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07301346",
"publication_url": "https://clinicaltrials.gov/study/NCT07301346",
"title": "EASEE® System Pivotal Study for the United States of America",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Precisis US, Inc.",
"sponsor_slug": "precisis-us-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07781657",
"publication_url": "https://clinicaltrials.gov/study/NCT07781657",
"title": "A Phase II, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of RO7568282 in Participants With Early Symptomatic Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07720167",
"publication_url": "https://clinicaltrials.gov/study/NCT07720167",
"title": "Neoadjuvant Chemo-Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07832630",
"publication_url": "https://clinicaltrials.gov/study/NCT07832630",
"title": "A Phase II Study of Saruparib in Patients With Platinum-Sensitive, HRDsig+ Solid Tumors",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Abramson Cancer Center at Penn Medicine",
"sponsor_slug": "abramson-cancer-center-at-penn-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07840482",
"publication_url": "https://clinicaltrials.gov/study/NCT07840482",
"title": "ClearPetra™ Vacuum-Assisted Ureteral Access Sheath Optimization of Irrigation and Suction Parameters in FANS-Assisted Flexible Ureteroscopy: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Kansas Medical Center",
"sponsor_slug": "university-of-kansas-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07768631",
"publication_url": "https://clinicaltrials.gov/study/NCT07768631",
"title": "A Prospective, Multicenter, Randomized, Sham-Controlled Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes (pULSENDO Study)",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Endogenex, Inc.",
"sponsor_slug": "endogenex-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04665206",
"publication_url": "https://clinicaltrials.gov/study/NCT04665206",
"title": "Phase I/II, Multi-Center, Open-Label Study of VT3989, Alone or in Combination, in Patients With Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2021-03-24",
"completion_date": "2029-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Vivace Therapeutics, Inc",
"sponsor_slug": "vivace-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07206056",
"publication_url": "https://clinicaltrials.gov/study/NCT07206056",
"title": "TulmiSTAR-01: A Two-part, Phase I Dose Escalation and Expansion Followed by a Randomized, Open-label Multicenter, Phase II Study to Assess the Safety and Efficacy of the Combination of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) vs Standard of Care in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2029-11-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07518238",
"publication_url": "https://clinicaltrials.gov/study/NCT07518238",
"title": "Comparative Effectiveness of Bupivacaine-Dexamethasone-Epinephrine Versus Exparel in Postoperative Outcomes for Hernia Patients Undergoing Abdominal Wall Reconstruction",
"has_exemption": false,
"start_date": "2026-01-13",
"completion_date": "2029-11-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor Research Institute",
"sponsor_slug": "baylor-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06698003",
"publication_url": "https://clinicaltrials.gov/study/NCT06698003",
"title": "A Phase 2 Study for Screening and Prevention of Adult T-cell Leukemia/Lymphoma With Mogamulizumab in High-Risk Carriers of HTLV-1",
"has_exemption": false,
"start_date": "2024-11-15",
"completion_date": "2029-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07052942",
"publication_url": "https://clinicaltrials.gov/study/NCT07052942",
"title": "Individualizing Treatment for Asthma in Primary Care (Full Study)",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2029-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "DARTNet Institute",
"sponsor_slug": "dartnet-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07252739",
"publication_url": "https://clinicaltrials.gov/study/NCT07252739",
"title": "KEYMAKER-U01 Substudy 01J: A Randomized Phase 2 Umbrella Study With Rolling Arms of Investigational Agents for First-line Treatment of Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With KRAS G12C Mutations",
"has_exemption": false,
"start_date": "2025-12-19",
"completion_date": "2029-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00117936",
"publication_url": "https://clinicaltrials.gov/study/NCT00117936",
"title": "Human Recombinant Fibroblast Growth Factor-1 (FGF-1), for the Treatment of Subjects With Severe Coronary Heart Disease, a Placebo Controlled, Double-blind, Dose-varying Study",
"has_exemption": false,
"start_date": "2027-09-01",
"completion_date": "2029-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Venturis Therapeutics, Inc.",
"sponsor_slug": "venturis-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06315322",
"publication_url": "https://clinicaltrials.gov/study/NCT06315322",
"title": "A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE LONG-TERM SAFETY AND TOLERABILITY OF BRIVARACETAM IN STUDY PARTICIPANTS WITH CHILDHOOD ABSENCE EPILEPSY OR JUVENILE ABSENCE EPILEPSY",
"has_exemption": false,
"start_date": "2024-07-10",
"completion_date": "2029-11-16",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05526755",
"publication_url": "https://clinicaltrials.gov/study/NCT05526755",
"title": "An Open-label, Single-arm, Phase II, Multinational, Multicentre Study to Assess the Efficacy and Safety of 5 Years of Osimertinib in Participants With EGFRm-positive Stage II-IIIB NSCLC, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy",
"has_exemption": false,
"start_date": "2023-03-06",
"completion_date": "2029-11-22",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07441408",
"publication_url": "https://clinicaltrials.gov/study/NCT07441408",
"title": "An Open-label, Multi-center, Long-term Extension Study to Evaluate the Long-term Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis",
"has_exemption": false,
"start_date": "2026-12-16",
"completion_date": "2029-11-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05636618",
"publication_url": "https://clinicaltrials.gov/study/NCT05636618",
"title": "A Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Tumors",
"has_exemption": false,
"start_date": "2023-09-27",
"completion_date": "2029-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Perspective Therapeutics",
"sponsor_slug": "perspective-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07190209",
"publication_url": "https://clinicaltrials.gov/study/NCT07190209",
"title": "A Phase 2b/Phase 3, Randomized, Double-blind, Placebocontrolled, Multicenter Study, to Investigate the Efficacy and Safety of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype",
"has_exemption": false,
"start_date": "2025-09-16",
"completion_date": "2029-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07190222",
"publication_url": "https://clinicaltrials.gov/study/NCT07190222",
"title": "A Phase 2b/Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study, to Investigate the Efficacy and Safety of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype",
"has_exemption": false,
"start_date": "2025-09-17",
"completion_date": "2029-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07293351",
"publication_url": "https://clinicaltrials.gov/study/NCT07293351",
"title": "ROSETTA RCC-208: A Phase 1/2 Open-label, Multi-center, Randomized Study of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC)",
"has_exemption": false,
"start_date": "2026-03-26",
"completion_date": "2029-11-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06008756",
"publication_url": "https://clinicaltrials.gov/study/NCT06008756",
"title": "Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk",
"has_exemption": false,
"start_date": "2023-10-09",
"completion_date": "2029-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187401",
"publication_url": "https://clinicaltrials.gov/study/NCT07187401",
"title": "A Randomized, Double-Blind, Placebo-Controlled, First-In-Human Study of the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ALN-CFB, an Investigational siRNA Therapeutic Against Complement Factor B, in Participants With Paroxysmal Nocturnal Hemoglobinuria and Persistent Anemia on Approved C5-Inhibitor Therapy",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2029-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03769766",
"publication_url": "https://clinicaltrials.gov/study/NCT03769766",
"title": "A Randomized, Double-Blind, Placebo-Controlled Trial of Curcumin to Prevent Progression of Biopsy Proven, Low-risk Localized Prostate Cancer Patients Undergoing Active Surveillance",
"has_exemption": false,
"start_date": "2019-03-11",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04408625",
"publication_url": "https://clinicaltrials.gov/study/NCT04408625",
"title": "A Phase 1/2 Ascending Dose Study to Evaluate the Safety and Effects on Progranulin Levels of LY3884963 in Patients With Fronto-Temporal Dementia With Progranulin Mutations (FTD-GRN)",
"has_exemption": false,
"start_date": "2020-11-09",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05533775",
"publication_url": "https://clinicaltrials.gov/study/NCT05533775",
"title": "A Phase I/II, Open-Label, Single-Arm, Two-Part Trial to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination With Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2022-11-16",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03762395",
"publication_url": "https://clinicaltrials.gov/study/NCT03762395",
"title": "Anti Inflammatory Lipid Mediators in Asthma: A Double Blind Placebo Control Cross Over, Proof of Concept Study of CXA-10 to Reduce Bronchial Hyperresponsiveness in Obese Asthmatics; Lipid Anti-Inflammatory Mediators in Asthma to Reduce Hyperresponsiveness in Obese Asthmatics",
"has_exemption": false,
"start_date": "2023-02-08",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05898646",
"publication_url": "https://clinicaltrials.gov/study/NCT05898646",
"title": "Phase II Study Evaluating Maintenance in Light Chain Amyloidosis (EMILIA)",
"has_exemption": false,
"start_date": "2023-09-06",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06163430",
"publication_url": "https://clinicaltrials.gov/study/NCT06163430",
"title": "A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia",
"has_exemption": false,
"start_date": "2024-03-26",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",
"sponsor_slug": "terns-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05796908",
"publication_url": "https://clinicaltrials.gov/study/NCT05796908",
"title": "A Prospective, Multi-Center, Single-Arm Clinical Trial of the Safety and Effectiveness of the Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.",
"has_exemption": false,
"start_date": "2024-04-12",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Aptis Medical",
"sponsor_slug": "aptis-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05998031",
"publication_url": "https://clinicaltrials.gov/study/NCT05998031",
"title": "A Mechanistic Study to Investigate tDCS and Working Memory in MCI Patients",
"has_exemption": false,
"start_date": "2024-04-24",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06461897",
"publication_url": "https://clinicaltrials.gov/study/NCT06461897",
"title": "A Phase 3, Open-label, Efficacy-Assessor-Blinded Study, Comparing the Safety and Efficacy of Upadacitinib to Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2024-08-19",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06951906",
"publication_url": "https://clinicaltrials.gov/study/NCT06951906",
"title": "Imaging Biomarkers of Freezing of Gait Response to Deep Brain Stimulation",
"has_exemption": false,
"start_date": "2024-11-11",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06399263",
"publication_url": "https://clinicaltrials.gov/study/NCT06399263",
"title": "Study of Psilocybin for Anorexia in Young Adults",
"has_exemption": false,
"start_date": "2024-11-18",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Marissa Raymond-Flesch, MD, MPH",
"sponsor_slug": "marissa-raymond-flesch-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06697184",
"publication_url": "https://clinicaltrials.gov/study/NCT06697184",
"title": "A Phase 1/2 Open-label Study to Investigate the Safety of Sonrotoclax Ramp-up Schedule(s) in Adult Patients With Hematological Malignancies.",
"has_exemption": false,
"start_date": "2025-01-23",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679634",
"publication_url": "https://clinicaltrials.gov/study/NCT06679634",
"title": "Retinoblastoma Phase II Expanded Access Clinical Trial",
"has_exemption": false,
"start_date": "2025-02-21",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Targeted Therapy Technologies, LLC",
"sponsor_slug": "targeted-therapy-technologies-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06668493",
"publication_url": "https://clinicaltrials.gov/study/NCT06668493",
"title": "A Phase 1/2, Single-arm, Open-Label Trial to Evaluate the Safety and Efficacy of Nadofaragene Firadenovec Instilled to the Renal Pelvis in Adult Subjects With Low-grade Upper Tract Urothelial Carcinoma (LG-UTUC)",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ferring Pharmaceuticals",
"sponsor_slug": "ferring-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07023289",
"publication_url": "https://clinicaltrials.gov/study/NCT07023289",
"title": "A Phase 2, Randomized, Open-Label Study Comparing Telisotuzumab Adizutecan (ABBV-400) Monotherapy to the Current Standard of Care in Subjects With Post Adjuvant ctDNA Positive Colorectal Cancer and No Radiographic Evidence of Disease (NED)",
"has_exemption": false,
"start_date": "2025-09-02",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07069738",
"publication_url": "https://clinicaltrials.gov/study/NCT07069738",
"title": "Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07207369",
"publication_url": "https://clinicaltrials.gov/study/NCT07207369",
"title": "A Multicenter, Cohort-design, Double-blind, Randomized, Parallel-group, Controlled Study to Evaluate the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07095868",
"publication_url": "https://clinicaltrials.gov/study/NCT07095868",
"title": "A Phase I/IIa Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 as Monotherapy and in Combination With Pembrolizumab in Patients With Selected Solid Tumors",
"has_exemption": false,
"start_date": "2025-11-17",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Everest Medicines (Beijing) Co., Ltd.",
"sponsor_slug": "everest-medicines-beijing-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07188805",
"publication_url": "https://clinicaltrials.gov/study/NCT07188805",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Investigate the Efficacy, Safety, and PK/ PD of Finerenone, in Addition to Standard-of-care, in Pediatric Patients, 6 Months to < 18 Years of Age With Heart Failure (HF) and Left Ventricular Systolic Dysfunction (LVSD)",
"has_exemption": false,
"start_date": "2025-11-19",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bayer",
"sponsor_slug": "bayer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284290",
"publication_url": "https://clinicaltrials.gov/study/NCT07284290",
"title": "Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia",
"has_exemption": false,
"start_date": "2025-12-08",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07398157",
"publication_url": "https://clinicaltrials.gov/study/NCT07398157",
"title": "Subgaleal Cortical Electrodes in Patients With Parkinson's Disease Undergoing Deep-brain Stimulation Therapy for Sensing and Adaptive Deep-brain Stimulation Over a 24-hour Period.",
"has_exemption": false,
"start_date": "2026-04-09",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07429240",
"publication_url": "https://clinicaltrials.gov/study/NCT07429240",
"title": "A Phase 1/2a, Multi-center, Open-label Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of PBGENE-DMD in Participants With Duchenne Muscular Dystrophy (FUNCTION-DMD)",
"has_exemption": false,
"start_date": "2026-04-24",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Precision BioSciences, Inc.",
"sponsor_slug": "precision-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07188896",
"publication_url": "https://clinicaltrials.gov/study/NCT07188896",
"title": "A Randomized Phase 2 Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)",
"has_exemption": false,
"start_date": "2026-04-29",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brian Rini",
"sponsor_slug": "brian-rini",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06224673",
"publication_url": "https://clinicaltrials.gov/study/NCT06224673",
"title": "Phase II Open-label Study of ARX788 (Anti-HER2 Antibody Drug Conjugate (ADC)) for Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2026-06-05",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Laura Huppert, MD, BA",
"sponsor_slug": "laura-huppert-md-ba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179315",
"publication_url": "https://clinicaltrials.gov/study/NCT07179315",
"title": "A Randomized Phase II Trial of Cemiplimab With or Without Fianlimab in Patients With Detectable Minimal-residual Disease After Definitive Treatment for Human Papillomavirus Positive HPV(+) Head and Neck Cancer.",
"has_exemption": false,
"start_date": "2026-06-09",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284602",
"publication_url": "https://clinicaltrials.gov/study/NCT07284602",
"title": "A Randomized, Double-Blind, Head-to-Head Phase 3 Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone at 52 Weeks in Adults With Idiopathic Pulmonary Fibrosis (SURPASS-IPF)",
"has_exemption": false,
"start_date": "2026-06-26",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PureTech",
"sponsor_slug": "puretech",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216391",
"publication_url": "https://clinicaltrials.gov/study/NCT07216391",
"title": "Adaptive Platform Trial to Delay Progression From Stage 2 to Stage 3 Type 1 Diabetes: Comparing Teplizumab With Low-dose Anti-Thymocyte Globulin (ATG) Protocol TN-40A",
"has_exemption": false,
"start_date": "2026-07-29",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07171489",
"publication_url": "https://clinicaltrials.gov/study/NCT07171489",
"title": "An Early Feasibility Study of Using the AccelBand, a Leg-worn Transcutaneous Neuromodulation (TNM) Device, for Neurogenic Bowel Dysfunction (NBD) in People With Spinal Cord Injury (SCI)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07722182",
"publication_url": "https://clinicaltrials.gov/study/NCT07722182",
"title": "A Pragmatic Randomised Trial Comparing Navigation Bronchoscopy-guided Microwave Ablation Versus Stereotactic Body Radiotherapy for Medically Inoperable or Surgery-declining Early-stage Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-08-10",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Chinese University of Hong Kong",
"sponsor_slug": "chinese-university-of-hong-kong",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07688577",
"publication_url": "https://clinicaltrials.gov/study/NCT07688577",
"title": "A First-in-Human, Multicenter, Phase 1/2, Open-Label Study of XTX501 in Participants With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Xilio Development, Inc.",
"sponsor_slug": "xilio-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07772024",
"publication_url": "https://clinicaltrials.gov/study/NCT07772024",
"title": "A Phase 3, Multicenter, Open-Label, Randomized Study to Evaluate Inobrodib in Combination With Pomalidomide and Dexamethasone Versus Standard Available Therapy in Patients With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CellCentric Ltd.",
"sponsor_slug": "cellcentric-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07606664",
"publication_url": "https://clinicaltrials.gov/study/NCT07606664",
"title": "Fezolinetant and Vascular Health and Brain Health",
"has_exemption": false,
"start_date": "2026-09-25",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rebecca Thurston",
"sponsor_slug": "rebecca-thurston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07094542",
"publication_url": "https://clinicaltrials.gov/study/NCT07094542",
"title": "Temporo-masseteric Nerve Block in Post-wisdom Tooth Extraction Pain- a Randomized Study",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07342439",
"publication_url": "https://clinicaltrials.gov/study/NCT07342439",
"title": "Phase 3 Study of Serine Supplementation to Protect Vision in MacTel",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Lowy Medical Research Institute Limited",
"sponsor_slug": "the-lowy-medical-research-institute-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00610051",
"publication_url": "https://clinicaltrials.gov/study/NCT00610051",
"title": "Phase 3 Study of Alprostadil Continuous Intravenous Infusion to Maintain Clinical Stability in Severe Heart Failure Patients",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Biopeutics Co., Ltd",
"sponsor_slug": "biopeutics-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07811271",
"publication_url": "https://clinicaltrials.gov/study/NCT07811271",
"title": "A Phase 3, Open-label, Multicenter, Randomized Study of BG-C9074 With Bevacizumab Versus Bevacizumab as First-line Maintenance Therapy for Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers Who Have Not Progressed After First-line Platinum-based Chemotherapy Plus Bevacizumab (Starstone-Ovarian 301/GOG-3144/ENGOT-ov108/APGOT-OV29)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07866573",
"publication_url": "https://clinicaltrials.gov/study/NCT07866573",
"title": "UltraTrac for Noninvasive Cardiac Output Monitoring in Patients With Congenital Heart Disease: A Multi-Setting Pilot Feasibility Study",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04414917",
"publication_url": "https://clinicaltrials.gov/study/NCT04414917",
"title": "Reducing Opioid Use/Misuse Through Better Pain Control and Active Pill Dispensing",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06660862",
"publication_url": "https://clinicaltrials.gov/study/NCT06660862",
"title": "DAROSTEP: Evaluating Step Counts as a Biomarker and Its Relationship on Treatment Outcomes in Vulnerable Patients With Metastatic Hormone-Sensitive Prostate Cancer on Darolutamide and Androgen Deprivation Therapy",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224763",
"publication_url": "https://clinicaltrials.gov/study/NCT07224763",
"title": "EXTEND: A Prospective Study to Evaluate the Safety and Efficacy of GGTA1 KO Thymokidney XenoTransplantation in Patients With End-stage Renal Disease (ESRD)",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "United Therapeutics",
"sponsor_slug": "united-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07793552",
"publication_url": "https://clinicaltrials.gov/study/NCT07793552",
"title": "Needlefree Lidocaine JTip Application for Pain Optimization in Vulvar Biopsies",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Tufts Medical Center",
"sponsor_slug": "tufts-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07838311",
"publication_url": "https://clinicaltrials.gov/study/NCT07838311",
"title": "Randomized Controlled Study of Delayed-Release, Extended-Release Methylphenidate (Jornay PM) in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Co-Occurring Cannabis Use Disorder",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07862205",
"publication_url": "https://clinicaltrials.gov/study/NCT07862205",
"title": "Closed-Loop Electroencephalography Optimized Transcranial Magnetic Stimulation Pilot Study for Advanced Treatment Outcomes in Adults With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01581580",
"publication_url": "https://clinicaltrials.gov/study/NCT01581580",
"title": "Deep Brain Stimulation Surgery for Movement Disorders",
"has_exemption": false,
"start_date": "2011-08-17",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Neurological Disorders and Stroke (NINDS)",
"sponsor_slug": "national-institute-of-neurological-disorders-and-stroke-ninds",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03643861",
"publication_url": "https://clinicaltrials.gov/study/NCT03643861",
"title": "RAD 1802: A Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)",
"has_exemption": false,
"start_date": "2019-08-20",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04374305",
"publication_url": "https://clinicaltrials.gov/study/NCT04374305",
"title": "Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)",
"has_exemption": false,
"start_date": "2020-06-20",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Scott R. Plotkin, MD, PhD",
"sponsor_slug": "scott-r-plotkin-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04532424",
"publication_url": "https://clinicaltrials.gov/study/NCT04532424",
"title": "Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD",
"has_exemption": false,
"start_date": "2021-01-04",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04240054",
"publication_url": "https://clinicaltrials.gov/study/NCT04240054",
"title": "A Multisite, Phase II Study of Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone (VICD) Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05154669",
"publication_url": "https://clinicaltrials.gov/study/NCT05154669",
"title": "Integrating Financial Coaching and Smoking Cessation Coaching for People With Low Income Who Smoke: a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2022-12-08",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06043817",
"publication_url": "https://clinicaltrials.gov/study/NCT06043817",
"title": "First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations",
"has_exemption": false,
"start_date": "2023-09-26",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Pierre Fabre Medicament",
"sponsor_slug": "pierre-fabre-medicament",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06447103",
"publication_url": "https://clinicaltrials.gov/study/NCT06447103",
"title": "89Zr-DFO-GmAb PET/CT vs Contrast-Enhanced CT for Detection of Recurrent Clear Cell Renal Cell Carcinoma After Surgery",
"has_exemption": false,
"start_date": "2024-08-06",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06739356",
"publication_url": "https://clinicaltrials.gov/study/NCT06739356",
"title": "North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia",
"has_exemption": false,
"start_date": "2025-03-04",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05766839",
"publication_url": "https://clinicaltrials.gov/study/NCT05766839",
"title": "A 2-Part, Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children Under 12 Years of Age With Hyperkalaemia (EMERALD2)",
"has_exemption": false,
"start_date": "2025-04-06",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vifor Pharma, Inc.",
"sponsor_slug": "vifor-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07166172",
"publication_url": "https://clinicaltrials.gov/study/NCT07166172",
"title": "North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07483294",
"publication_url": "https://clinicaltrials.gov/study/NCT07483294",
"title": "Cerebellar-cortical Circuitry and Prediction of Treatment Response in Early Psychosis",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222215",
"publication_url": "https://clinicaltrials.gov/study/NCT07222215",
"title": "A Phase II Multi-Center Open-label Randomized Study of CAPecitabine in Combination With ELAcestrant Versus Capecitabine Alone in Advanced Estrogen Receptor-Positive Breast Cancer (CAPELA)",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Kristina A. Fanucci",
"sponsor_slug": "kristina-a-fanucci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096778",
"publication_url": "https://clinicaltrials.gov/study/NCT07096778",
"title": "A Phase II, Open-Label, Multicenter Study of Inobrodib in Combination With Pomalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-01-22",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "CellCentric Ltd.",
"sponsor_slug": "cellcentric-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07510607",
"publication_url": "https://clinicaltrials.gov/study/NCT07510607",
"title": "Assessing Metabolic Changes in Multiple Sclerosis Using Hyper-polarized Carbon 13 MRI",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ari Green",
"sponsor_slug": "ari-green",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07721493",
"publication_url": "https://clinicaltrials.gov/study/NCT07721493",
"title": "An Assessment of the Safety and Effectiveness of the CORUS™ Posterior Cervical Stabilization System 3D (PCSS 3D) to Determine Superiority to ANterior Cervical Discectomy and Fusion (ACDF) in the Treatment of 2-Level Cervical Degenerative Disease",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Providence Medical Technology, Inc.",
"sponsor_slug": "providence-medical-technology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06552000",
"publication_url": "https://clinicaltrials.gov/study/NCT06552000",
"title": "Phase 0 Trial of Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854029",
"publication_url": "https://clinicaltrials.gov/study/NCT06854029",
"title": "Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07690891",
"publication_url": "https://clinicaltrials.gov/study/NCT07690891",
"title": "Phase II Study of Nemtabrutinib With Venetoclax and Obinutuzumab in Patients With Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07296094",
"publication_url": "https://clinicaltrials.gov/study/NCT07296094",
"title": "Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial",
"has_exemption": false,
"start_date": "2026-11-15",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07808138",
"publication_url": "https://clinicaltrials.gov/study/NCT07808138",
"title": "RADICAL-IO: thRee Cycles of immunotherApy Without raDical Therapy In mediCALly InOperable Stage I Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The Netherlands Cancer Institute",
"sponsor_slug": "the-netherlands-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05479643",
"publication_url": "https://clinicaltrials.gov/study/NCT05479643",
"title": "A Pilot Study for a Novel and Personalized Voice Restoration Device for Patients With Laryngectomy",
"has_exemption": false,
"start_date": "2027-12-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05130437",
"publication_url": "https://clinicaltrials.gov/study/NCT05130437",
"title": "A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study",
"has_exemption": false,
"start_date": "2021-11-09",
"completion_date": "2029-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06449651",
"publication_url": "https://clinicaltrials.gov/study/NCT06449651",
"title": "Double-blind, Randomized, Placebo-controlled Study Evaluating the Safety and Efficacy of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) in At-risk Pregnancies",
"has_exemption": false,
"start_date": "2024-11-11",
"completion_date": "2029-12-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07190248",
"publication_url": "https://clinicaltrials.gov/study/NCT07190248",
"title": "A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084 in Combination With Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) Versus MK-3475A in Combination With Pemetrexed/Platinum (Carboplatin or Cisplatin) Chemotherapy as First-line Treatment of Participants With KRAS G12C-Mutant, Advanced or Metastatic Nonsquamous NSCLC (KANDLELIT-007)",
"has_exemption": false,
"start_date": "2025-10-08",
"completion_date": "2029-12-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07623161",
"publication_url": "https://clinicaltrials.gov/study/NCT07623161",
"title": "A Phase 3, Double-Blind, Randomized Trial Evaluating the Efficacy and Safety of Elritercept (TAK-226) Compared to Placebo in Participants With Myelofibrosis and Anemia on Concurrent Ruxolitinib Therapy",
"has_exemption": false,
"start_date": "2026-09-10",
"completion_date": "2029-12-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04938817",
"publication_url": "https://clinicaltrials.gov/study/NCT04938817",
"title": "A Phase 1b/2 Study to Evaluate the Efficacy and Safety of Investigational Agents as Monotherapy or in Combination With Pembrolizumab for the Treatment of Participants With PD-1/L1-refractory Extensive-Stage Small Cell Lung Cancer in Need of Second-Line Therapy (KEYNOTE-B98)",
"has_exemption": false,
"start_date": "2021-08-19",
"completion_date": "2029-12-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06804642",
"publication_url": "https://clinicaltrials.gov/study/NCT06804642",
"title": "Rehabilitation of Locomotor Function in Parkinson's Disease by Non-invasive Spinal Cord Stimulation",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2029-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06747949",
"publication_url": "https://clinicaltrials.gov/study/NCT06747949",
"title": "A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjögren's Syndrome (SS)",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2029-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07508982",
"publication_url": "https://clinicaltrials.gov/study/NCT07508982",
"title": "Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML",
"has_exemption": false,
"start_date": "2026-05-22",
"completion_date": "2029-12-12",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07740720",
"publication_url": "https://clinicaltrials.gov/study/NCT07740720",
"title": "A Phase 3b, Open-label Study Investigating the Duration of Neoadjuvant Dostarlimab Monotherapy in Participants With Untreated Stage II/III dMMR/MSI-H Locally Advanced Rectal Cancer",
"has_exemption": false,
"start_date": "2026-09-17",
"completion_date": "2029-12-12",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06652438",
"publication_url": "https://clinicaltrials.gov/study/NCT06652438",
"title": "Randomized Study to Assess Revumenib in Combination With Azacitidine + Venetoclax in Adult Patients With Newly Diagnosed NPM1-mutated or KMT2A-rearranged AML Ineligible for Intensive Chemotherapy",
"has_exemption": false,
"start_date": "2025-05-05",
"completion_date": "2029-12-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Stichting Hemato-Oncologie voor Volwassenen Nederland",
"sponsor_slug": "stichting-hemato-oncologie-voor-volwassenen-nederland",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07544654",
"publication_url": "https://clinicaltrials.gov/study/NCT07544654",
"title": "A Phase III, Multi-center, Open-label, Randomised, Controlled Trial of Intravenous Obrixtamig in Combination With Carboplatin and Etoposide vs. Carboplatin and Etoposide as First-line Therapy in DLL3-positive Patients With Unresectable Locally Advanced or Metastatic Extrapulmonary Neuroendocrine Carcinomas",
"has_exemption": false,
"start_date": "2026-07-10",
"completion_date": "2029-12-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064473",
"publication_url": "https://clinicaltrials.gov/study/NCT07064473",
"title": "EASi-PROTKT™ - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Type 2 Diabetes, Hypertension and Established Cardiovascular Disease",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2029-12-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06101290",
"publication_url": "https://clinicaltrials.gov/study/NCT06101290",
"title": "Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)",
"has_exemption": false,
"start_date": "2023-12-05",
"completion_date": "2029-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07876492",
"publication_url": "https://clinicaltrials.gov/study/NCT07876492",
"title": "A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to Evaluate Cenvacibart (REGN7508), a Monoclonal Antibody Against Factor XI, for Secondary Stroke Prevention (ROXI-DAISEN)",
"has_exemption": false,
"start_date": "2026-11-20",
"completion_date": "2029-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06677060",
"publication_url": "https://clinicaltrials.gov/study/NCT06677060",
"title": "A Phase III, Randomised, Placebo-controlled, Event-driven Study to Evaluate the Effect of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on the Risk of Incident Heart Failure and Cardiovascular Death",
"has_exemption": false,
"start_date": "2025-03-14",
"completion_date": "2029-12-17",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06380751",
"publication_url": "https://clinicaltrials.gov/study/NCT06380751",
"title": "A Randomised, Open-Label, Phase III Study of Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With Physician's Choice CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant for the First-Line Treatment of Patients With BRCA1, BRCA2, or PALB2 Mutations and Hormone Receptor Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified) Advanced Breast Cancer (EvoPAR-Breast01)",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06542250",
"publication_url": "https://clinicaltrials.gov/study/NCT06542250",
"title": "A Modular Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With Relapsed or Refractory B-Cell Malignancies (TITANium)",
"has_exemption": false,
"start_date": "2024-09-18",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06742723",
"publication_url": "https://clinicaltrials.gov/study/NCT06742723",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled, Event-driven Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on Renal Outcomes and Cardiovascular Mortality in Participants With Chronic Kidney Disease and High Blood Pressure",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288567",
"publication_url": "https://clinicaltrials.gov/study/NCT07288567",
"title": "A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (13 to 17 Years of Age)",
"has_exemption": false,
"start_date": "2026-01-29",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286058",
"publication_url": "https://clinicaltrials.gov/study/NCT07286058",
"title": "A Phase 3, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Either Biologic DMARD-Naïve or Biologic DMARD-Experienced, Including Those With Inadequate Response to Biologic DMARDs",
"has_exemption": false,
"start_date": "2026-03-11",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07579429",
"publication_url": "https://clinicaltrials.gov/study/NCT07579429",
"title": "Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)",
"has_exemption": false,
"start_date": "2026-05-20",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07700056",
"publication_url": "https://clinicaltrials.gov/study/NCT07700056",
"title": "A 52-week Multi-center, Randomized, Double-blind, Placebo Controlled Phase 3 Study to Evaluate the Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)",
"has_exemption": false,
"start_date": "2026-08-24",
"completion_date": "2029-12-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03684018",
"publication_url": "https://clinicaltrials.gov/study/NCT03684018",
"title": "Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP",
"has_exemption": false,
"start_date": "2019-02-28",
"completion_date": "2029-12-20",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04684368",
"publication_url": "https://clinicaltrials.gov/study/NCT04684368",
"title": "A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor",
"has_exemption": false,
"start_date": "2021-07-13",
"completion_date": "2029-12-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907147",
"publication_url": "https://clinicaltrials.gov/study/NCT06907147",
"title": "Global Pilot Study of rEnal and Hepatic coMbINed denervatIon in Subjects With Uncontrolled Hypertension With and Without High Cardiovascular Risk",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2029-12-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Vascular",
"sponsor_slug": "medtronic-vascular",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05844982",
"publication_url": "https://clinicaltrials.gov/study/NCT05844982",
"title": "A Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss Due to Radiation Retinopathy",
"has_exemption": false,
"start_date": "2023-11-21",
"completion_date": "2029-12-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaeb Center for Health Research",
"sponsor_slug": "jaeb-center-for-health-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07459504",
"publication_url": "https://clinicaltrials.gov/study/NCT07459504",
"title": "A Sequential Multiple Assignment Randomized Trial of Diet Treatments for Hepatic Steatosis and Cardiometabolic Risk in Youth",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-12-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Michigan State University",
"sponsor_slug": "michigan-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07444567",
"publication_url": "https://clinicaltrials.gov/study/NCT07444567",
"title": "ROSY-F: Roll-Over Study for Participants Who Have Completed a Previous Study With Benralizumab (Fasenra) and Are Judged by the Investigator to Clinically Benefit From Continued Treatment",
"has_exemption": false,
"start_date": "2026-07-24",
"completion_date": "2029-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06357533",
"publication_url": "https://clinicaltrials.gov/study/NCT06357533",
"title": "A Phase III, Randomised, Open-label, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Pembrolizumab Monotherapy for the First-line Treatment of Participants With Locally-advanced or Metastatic Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations (TROPION-Lung10)",
"has_exemption": false,
"start_date": "2024-04-11",
"completion_date": "2029-12-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07807995",
"publication_url": "https://clinicaltrials.gov/study/NCT07807995",
"title": "A Phase 3, Single-Arm, Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy",
"has_exemption": false,
"start_date": "2026-09-17",
"completion_date": "2029-12-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07770815",
"publication_url": "https://clinicaltrials.gov/study/NCT07770815",
"title": "A Phase 3, Open-label, Single-arm, Repeat-dose Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Sibeprenlimab Administered Subcutaneously in Children and Adolescents With Immunoglobulin A Nephropathy",
"has_exemption": false,
"start_date": "2026-10-30",
"completion_date": "2029-12-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Development & Commercialization, Inc.",
"sponsor_slug": "otsuka-pharmaceutical-development-commercialization-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03458429",
"publication_url": "https://clinicaltrials.gov/study/NCT03458429",
"title": "Safety and Efficacy of GMFFP From Young Healthy Donors (18-35), Treated With G-CSF to Ameliorate Frailty and Enhance the Immune Risk Profile in Older Individuals",
"has_exemption": false,
"start_date": "2018-02-05",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dipnarine Maharaj",
"sponsor_slug": "dipnarine-maharaj",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04061148",
"publication_url": "https://clinicaltrials.gov/study/NCT04061148",
"title": "Clinical Testing of Near Infrared Spectroscopy (NIRS) for Quantitative Assessment of Depression",
"has_exemption": false,
"start_date": "2019-01-04",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05910801",
"publication_url": "https://clinicaltrials.gov/study/NCT05910801",
"title": "Tafasitamab, Lenalidomide and Venetoclax Combination Therapy for Relapsed or Refractory Mantle Cell Lymphoma (V-MIND): a Phase II Study with Safety Lead-In",
"has_exemption": false,
"start_date": "2024-01-04",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Academic and Community Cancer Research United",
"sponsor_slug": "academic-and-community-cancer-research-united",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06660654",
"publication_url": "https://clinicaltrials.gov/study/NCT06660654",
"title": "REJOICE-PanTumor01: A Phase 2, Multicenter, Open-Label, Pan-Tumor Trial to Evaluate Efficacy and Safety of Raludotatug Deruxtecan (R-DXd) in Participants With Advanced/Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06764615",
"publication_url": "https://clinicaltrials.gov/study/NCT06764615",
"title": "A Phase 2, Open-Label Extension Trial to Evaluate the Long-term Safety and Tolerability of Oral Zasocitinib (TAK-279) in Participants With Moderately to Severely Active Ulcerative Colitis and Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07804004",
"publication_url": "https://clinicaltrials.gov/study/NCT07804004",
"title": "A Phase 1/2 Dose Evaluation Trial of the Safety and Preliminary Efficacy of Anti-CD19 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX112) in Adult Participants With Refractory Neurologic Autoimmune Disease.",
"has_exemption": false,
"start_date": "2026-09-15",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CRISPR Therapeutics",
"sponsor_slug": "crispr-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05569486",
"publication_url": "https://clinicaltrials.gov/study/NCT05569486",
"title": "Elucidating the Central Mechanism(s) of Action for Green Light Therapy in Managing Chronic Pain",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00262470",
"publication_url": "https://clinicaltrials.gov/study/NCT00262470",
"title": "Treatment of Orthostatic Intolerance",
"has_exemption": false,
"start_date": "1997-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Satish R. Raj",
"sponsor_slug": "satish-r-raj",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT00900497",
"publication_url": "https://clinicaltrials.gov/study/NCT00900497",
"title": "A Phase I/II Study For the Use of White Blood Cells From Healthy Donor-participants To Treat Subjects With Solid Cancers",
"has_exemption": false,
"start_date": "2009-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dipnarine Maharaj",
"sponsor_slug": "dipnarine-maharaj",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01841723",
"publication_url": "https://clinicaltrials.gov/study/NCT01841723",
"title": "A Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 (Ibrutinib) for Treatment of Relapsed Hairy Cell Leukemia",
"has_exemption": false,
"start_date": "2013-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02582697",
"publication_url": "https://clinicaltrials.gov/study/NCT02582697",
"title": "Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours",
"has_exemption": false,
"start_date": "2014-02-28",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Sydney",
"sponsor_slug": "university-of-sydney",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06984757",
"publication_url": "https://clinicaltrials.gov/study/NCT06984757",
"title": "Mid-frontal Delta/Theta and Cognitive Control",
"has_exemption": false,
"start_date": "2017-09-25",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nandakumar Narayanan",
"sponsor_slug": "nandakumar-narayanan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03373968",
"publication_url": "https://clinicaltrials.gov/study/NCT03373968",
"title": "Open Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT Studies",
"has_exemption": false,
"start_date": "2017-10-24",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Italfarmaco",
"sponsor_slug": "italfarmaco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03998527",
"publication_url": "https://clinicaltrials.gov/study/NCT03998527",
"title": "Non-Invasive Spinal Cord Stimulation and Respiratory Plasticity",
"has_exemption": false,
"start_date": "2018-05-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03599765",
"publication_url": "https://clinicaltrials.gov/study/NCT03599765",
"title": "External Beam Radiation to Eliminate Nominal Metastatic Disease (EXTEND): A Randomized Phase II Basket Trial Assessing the Efficacy of Upfront Local Consolidative Therapy (LCT) for Oligometastatic Disease",
"has_exemption": false,
"start_date": "2018-07-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03683251",
"publication_url": "https://clinicaltrials.gov/study/NCT03683251",
"title": "A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Portal)",
"has_exemption": false,
"start_date": "2018-09-20",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03919292",
"publication_url": "https://clinicaltrials.gov/study/NCT03919292",
"title": "Phase 1/2 Study of Neratinib and Divalproex Sodium (Valproate) in Advanced Solid Tumors, With an Expansion Cohort in Ras-Mutated Cancers",
"has_exemption": false,
"start_date": "2019-05-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03474029",
"publication_url": "https://clinicaltrials.gov/study/NCT03474029",
"title": "Six Weeks of Daily Rifapentine vs. a Comparator Arm of 12-16 Week Rifamycin-based Treatment of Latent M. Tuberculosis Infection: Assessment of Safety, Tolerability and Effectiveness",
"has_exemption": false,
"start_date": "2019-08-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Centers for Disease Control and Prevention",
"sponsor_slug": "centers-for-disease-control-and-prevention",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03937635",
"publication_url": "https://clinicaltrials.gov/study/NCT03937635",
"title": "Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)",
"has_exemption": false,
"start_date": "2019-09-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04166318",
"publication_url": "https://clinicaltrials.gov/study/NCT04166318",
"title": "A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)",
"has_exemption": false,
"start_date": "2020-01-02",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03971799",
"publication_url": "https://clinicaltrials.gov/study/NCT03971799",
"title": "Phase 1/2 Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2020-01-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Center for International Blood and Marrow Transplant Research",
"sponsor_slug": "center-for-international-blood-and-marrow-transplant-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04516135",
"publication_url": "https://clinicaltrials.gov/study/NCT04516135",
"title": "A Randomized Phase II Trial of Palliative Pelvic Radiation Therapy to Improve Health Related Quality of Life in Gynecologic Malignancies",
"has_exemption": false,
"start_date": "2021-01-11",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04661358",
"publication_url": "https://clinicaltrials.gov/study/NCT04661358",
"title": "A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening",
"has_exemption": false,
"start_date": "2021-03-05",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaeb Center for Health Research",
"sponsor_slug": "jaeb-center-for-health-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04474847",
"publication_url": "https://clinicaltrials.gov/study/NCT04474847",
"title": "A Randomized Double-Blind, Placebo Controlled Trial of Abatacept (CTLA4-Ig) in Giant Cell Arteritis (ABAGART)",
"has_exemption": false,
"start_date": "2021-03-29",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04774159",
"publication_url": "https://clinicaltrials.gov/study/NCT04774159",
"title": "Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk: A Randomized Trial",
"has_exemption": false,
"start_date": "2021-05-06",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Population Health Research Institute",
"sponsor_slug": "population-health-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05099770",
"publication_url": "https://clinicaltrials.gov/study/NCT05099770",
"title": "A Phase 3 Randomized Controlled Study of Renal Autologous Cell Therapy (REACT) in Subjects With Type 2 Diabetes and Chronic Kidney Disease (REGEN-006)",
"has_exemption": false,
"start_date": "2022-01-05",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prokidney",
"sponsor_slug": "prokidney",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05183646",
"publication_url": "https://clinicaltrials.gov/study/NCT05183646",
"title": "A Pivotal Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of DMX-200 in Patients With Focal Segmental Glomerulosclerosis (FSGS) Who Are Receiving an Angiotensin II Receptor Blocker (ARB)",
"has_exemption": false,
"start_date": "2022-05-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dimerix Bioscience Pty Ltd",
"sponsor_slug": "dimerix-bioscience-pty-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05226871",
"publication_url": "https://clinicaltrials.gov/study/NCT05226871",
"title": "A TREATMENT PROTOCOL FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED PALBOCICLIB CLINICAL STUDIES",
"has_exemption": false,
"start_date": "2022-07-07",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06946264",
"publication_url": "https://clinicaltrials.gov/study/NCT06946264",
"title": "Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic Features",
"has_exemption": false,
"start_date": "2022-07-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nemours Children's Clinic",
"sponsor_slug": "nemours-childrens-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04905693",
"publication_url": "https://clinicaltrials.gov/study/NCT04905693",
"title": "An Open-label Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease (TETON-OLE)",
"has_exemption": false,
"start_date": "2022-09-06",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "United Therapeutics",
"sponsor_slug": "united-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05409066",
"publication_url": "https://clinicaltrials.gov/study/NCT05409066",
"title": "A Phase 3, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination With Rituximab and Lenalidomide (R2) Compared to R2 in Subjects With Relapsed or Refractory Follicular Lymphoma (EPCORE FL-1)",
"has_exemption": false,
"start_date": "2022-09-20",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05527340",
"publication_url": "https://clinicaltrials.gov/study/NCT05527340",
"title": "Multicenter, Phase II, National and Open-label Study to Evaluate Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.",
"has_exemption": false,
"start_date": "2022-12-15",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "PETHEMA Foundation",
"sponsor_slug": "pethema-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05382338",
"publication_url": "https://clinicaltrials.gov/study/NCT05382338",
"title": "A Phase 3 Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children With Average-Risk Medulloblastoma and Reduced Therapy in Children With Medulloblastoma With Low-Risk Features",
"has_exemption": false,
"start_date": "2023-02-20",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05776069",
"publication_url": "https://clinicaltrials.gov/study/NCT05776069",
"title": "A Multi-Modular Trial to Evaluate VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease and Other Bleeding Disorders (VIVID)",
"has_exemption": false,
"start_date": "2023-03-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vega Therapeutics, Inc",
"sponsor_slug": "vega-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05526144",
"publication_url": "https://clinicaltrials.gov/study/NCT05526144",
"title": "Low Dose Thyroid Hormone, Mitochondrial Fatty Acid Oxidation, and Treatment of Nonalcoholic Steatohepatitis (NASH)",
"has_exemption": false,
"start_date": "2023-04-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05700721",
"publication_url": "https://clinicaltrials.gov/study/NCT05700721",
"title": "Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)",
"has_exemption": false,
"start_date": "2023-06-02",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05898620",
"publication_url": "https://clinicaltrials.gov/study/NCT05898620",
"title": "A Baseline-Controlled, Open-Label, Multicenter, Single-Arm, Pivotal Study to Evaluate the Efficacy, Safety, and Tolerability of NGN-401 in Subjects With Rett Syndrome (Embolden)",
"has_exemption": false,
"start_date": "2023-06-13",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurogene Inc.",
"sponsor_slug": "neurogene-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05361941",
"publication_url": "https://clinicaltrials.gov/study/NCT05361941",
"title": "Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities",
"has_exemption": false,
"start_date": "2023-08-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Elute, Inc.",
"sponsor_slug": "elute-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06103682",
"publication_url": "https://clinicaltrials.gov/study/NCT06103682",
"title": "LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)",
"has_exemption": false,
"start_date": "2023-10-05",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05616546",
"publication_url": "https://clinicaltrials.gov/study/NCT05616546",
"title": "Longitudinal Analysis of Bone Marrow and Peripheral Blood Immune Responses to Influenza Vaccination in a Healthy Adult Cohort",
"has_exemption": false,
"start_date": "2023-10-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06126380",
"publication_url": "https://clinicaltrials.gov/study/NCT06126380",
"title": "AT-1501-K209: BESTOW-EXTENSION: A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2023-10-25",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eledon Pharmaceuticals",
"sponsor_slug": "eledon-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05977751",
"publication_url": "https://clinicaltrials.gov/study/NCT05977751",
"title": "FINALE: Prospective Multi-Center Trial for FemBloc INtratubal Occlusion for TranscervicAL PErmanent Birth Control",
"has_exemption": false,
"start_date": "2023-10-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Femasys Inc.",
"sponsor_slug": "femasys-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06105749",
"publication_url": "https://clinicaltrials.gov/study/NCT06105749",
"title": "Outcome of Biennial Screening Contrast-Enhanced Mammography (CEM) in Women With a Personal History of Breast Cancer (PHBC)",
"has_exemption": false,
"start_date": "2023-11-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wendie Berg",
"sponsor_slug": "wendie-berg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06084234",
"publication_url": "https://clinicaltrials.gov/study/NCT06084234",
"title": "National Liver Cancer Screening Trial",
"has_exemption": false,
"start_date": "2023-12-26",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06238648",
"publication_url": "https://clinicaltrials.gov/study/NCT06238648",
"title": "Multicenter, Randomized Phase II Study of Epcoritamab for Patients With Aggressive B-Cell Lymphomas Achieving a Partial Response After CD19-Directed CAR-T Therapy",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Academic and Community Cancer Research United",
"sponsor_slug": "academic-and-community-cancer-research-united",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06264609",
"publication_url": "https://clinicaltrials.gov/study/NCT06264609",
"title": "Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover - Follow Up Study",
"has_exemption": false,
"start_date": "2024-02-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul F Netzel",
"sponsor_slug": "paul-f-netzel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06121297",
"publication_url": "https://clinicaltrials.gov/study/NCT06121297",
"title": "A Phase 1/2, Open-label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Active Systemic Lupus Erythematosus",
"has_exemption": false,
"start_date": "2024-02-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06227949",
"publication_url": "https://clinicaltrials.gov/study/NCT06227949",
"title": "FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients: an Exploratory Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ellen Greenblatt",
"sponsor_slug": "ellen-greenblatt",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06292208",
"publication_url": "https://clinicaltrials.gov/study/NCT06292208",
"title": "Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) and Preliminary Efficacy of IBD0333 in Patients With Locally Advanced/Metastatic Solid Tumor or Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2024-03-09",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SUNHO（China）BioPharmaceutical CO., Ltd.",
"sponsor_slug": "sunhochinabiopharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06216470",
"publication_url": "https://clinicaltrials.gov/study/NCT06216470",
"title": "Phase II Investigator-Initiated Study to Understand the Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University Health Network, Toronto",
"sponsor_slug": "university-health-network-toronto",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06172296",
"publication_url": "https://clinicaltrials.gov/study/NCT06172296",
"title": "A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2024-04-19",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06455137",
"publication_url": "https://clinicaltrials.gov/study/NCT06455137",
"title": "Epidural Electrical Stimulation for Spinal Cord Injury Patients and Corticospinal Motor Circuit Improvement",
"has_exemption": false,
"start_date": "2024-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Buddhist Tzu Chi General Hospital",
"sponsor_slug": "buddhist-tzu-chi-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06964152",
"publication_url": "https://clinicaltrials.gov/study/NCT06964152",
"title": "Prospective Use of Computational Cardiac Imaging Analysis to Guide Ventricular Tachycardia Ablation Procedures (AI-VT)",
"has_exemption": false,
"start_date": "2024-05-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06200103",
"publication_url": "https://clinicaltrials.gov/study/NCT06200103",
"title": "Minority-Inclusive Imaging Biomarker-Based End of Therapy Trial for 177Lu-PSMA-617, a Randomized De-Escalation Theranostic Trial for Metastatic Castrate Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2024-05-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06395402",
"publication_url": "https://clinicaltrials.gov/study/NCT06395402",
"title": "177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry",
"has_exemption": false,
"start_date": "2024-05-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Iowa",
"sponsor_slug": "university-of-iowa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06096259",
"publication_url": "https://clinicaltrials.gov/study/NCT06096259",
"title": "Preventing Injured Knees From osteoArthritis: Severity Outcomes (PIKASO)",
"has_exemption": false,
"start_date": "2024-05-06",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06215469",
"publication_url": "https://clinicaltrials.gov/study/NCT06215469",
"title": "Amma™ Portable Scalp Cooling System (PSCS) Study: A Post-market Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Early-stage Breast Cancer",
"has_exemption": false,
"start_date": "2024-05-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06207799",
"publication_url": "https://clinicaltrials.gov/study/NCT06207799",
"title": "Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-07-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06526338",
"publication_url": "https://clinicaltrials.gov/study/NCT06526338",
"title": "A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of IP-001 as Adjuvant Therapy in Participants With Hepatocellular Carcinoma After Complete Radiological Response After Surgical Resection and Local Ablation or Local Ablation Alone",
"has_exemption": false,
"start_date": "2024-07-24",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Robert C. Martin",
"sponsor_slug": "robert-c-martin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06107764",
"publication_url": "https://clinicaltrials.gov/study/NCT06107764",
"title": "Cerebellar Modulation of Cognition in Psychosis",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mclean Hospital",
"sponsor_slug": "mclean-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445946",
"publication_url": "https://clinicaltrials.gov/study/NCT06445946",
"title": "DECIDE: A Comparative Effectiveness Trial of Oral Metformin Versus Injectable Insulin for the Treatment of Gestational Diabetes",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06061809",
"publication_url": "https://clinicaltrials.gov/study/NCT06061809",
"title": "Open-Label, Single-Arm Phase 2 Study of Nogapendekin Alfa Inbakicept, PD-L1 t-haNK, Bevacizumab and Randomized Phase 2B Study of Nogapendekin Alfa Inbakicept, Bevacizumab, and Tumor Treatment Fields With or Without PD-L1 t-haNK in Participants With Recurrent or Progressive Glioblastoma",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06518551",
"publication_url": "https://clinicaltrials.gov/study/NCT06518551",
"title": "A Phase I Study of Elotuzumab and Iberdomide and Dexamethasone Post Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Omar Nadeem, MD",
"sponsor_slug": "omar-nadeem-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06500975",
"publication_url": "https://clinicaltrials.gov/study/NCT06500975",
"title": "Long Term Outcomes After Vestibular Implantation",
"has_exemption": false,
"start_date": "2024-12-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06735976",
"publication_url": "https://clinicaltrials.gov/study/NCT06735976",
"title": "Efficacy & Safety of LOBO™ Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations (PAVM)",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06711705",
"publication_url": "https://clinicaltrials.gov/study/NCT06711705",
"title": "Phase II MRD-Adapted Study of Elranatamab in Relapsed/Refractory",
"has_exemption": false,
"start_date": "2024-12-18",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06769633",
"publication_url": "https://clinicaltrials.gov/study/NCT06769633",
"title": "A Phase 2 Open-label (Core Phase Plus Extension Phase) With 2 Cohorts Study to Assess the Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Than 6 Years Old",
"has_exemption": false,
"start_date": "2025-01-02",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Italfarmaco",
"sponsor_slug": "italfarmaco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06132178",
"publication_url": "https://clinicaltrials.gov/study/NCT06132178",
"title": "Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06797635",
"publication_url": "https://clinicaltrials.gov/study/NCT06797635",
"title": "An Open-label Randomized Phase 2 Study to Evaluate Safety and Efficacy of Patritumab Deruxtecan Plus Pembrolizumab Administered Either Before or After Carboplatin/Paclitaxel Plus Pembrolizumab Compared With Pembrolizumab in Combination With Chemotherapy Followed by Surgery and Adjuvant Pembrolizumab for High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer (HERTHENA-Breast03)",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064018",
"publication_url": "https://clinicaltrials.gov/study/NCT07064018",
"title": "Phase Ib/IIa Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Irvine",
"sponsor_slug": "university-of-california-irvine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07003425",
"publication_url": "https://clinicaltrials.gov/study/NCT07003425",
"title": "A Long-term Extension Study to Evaluate the Safety and Efficacy of APG777 in Patients With Atopic Dermatitis Previously Treated With APG777",
"has_exemption": false,
"start_date": "2025-05-14",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Apogee Therapeutics, Inc.",
"sponsor_slug": "apogee-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06736171",
"publication_url": "https://clinicaltrials.gov/study/NCT06736171",
"title": "Prescription of Robotic Exoskeletons for Ambulation Recovery Post Stroke",
"has_exemption": false,
"start_date": "2025-05-15",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kessler Foundation",
"sponsor_slug": "kessler-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976801",
"publication_url": "https://clinicaltrials.gov/study/NCT06976801",
"title": "Prospective, Randomized-control Trial Comparing Standard Intramedullary Tibial Fixation With Micromotion Tibial Intramedullary Fixation",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06765109",
"publication_url": "https://clinicaltrials.gov/study/NCT06765109",
"title": "A Phase 3 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 Compared to Alectinib in First-Line Treatment of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (ALKAZAR)",
"has_exemption": false,
"start_date": "2025-07-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nuvalent Inc.",
"sponsor_slug": "nuvalent-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06508931",
"publication_url": "https://clinicaltrials.gov/study/NCT06508931",
"title": "A Single-arm, Multi-center, Open-label Phase II Study to Determine the Safety and Efficacy of MB-CART2019.1 in Pediatric Subjects With Relapsed/Refractory Mature B-cell Neoplasms Who Have Relapsed After One or More Prior Therapies, Including Subjects With Primary Refractory Disease",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Miltenyi Biomedicine GmbH",
"sponsor_slug": "miltenyi-biomedicine-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06740968",
"publication_url": "https://clinicaltrials.gov/study/NCT06740968",
"title": "Improving Neural Oscillation and Synchrony Between Motor and Auditory Regions in Stuttering Using Personalized Transcranial Alternating Current Stimulation (tACS)",
"has_exemption": false,
"start_date": "2025-08-05",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07144813",
"publication_url": "https://clinicaltrials.gov/study/NCT07144813",
"title": "Clinical Post- Approval Study of the Neuspera Sacral Neuromodulation (SNM) System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neuspera Medical, Inc.",
"sponsor_slug": "neuspera-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07174726",
"publication_url": "https://clinicaltrials.gov/study/NCT07174726",
"title": "A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Beacon Therapeutics",
"sponsor_slug": "beacon-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06561074",
"publication_url": "https://clinicaltrials.gov/study/NCT06561074",
"title": "A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)",
"has_exemption": false,
"start_date": "2025-09-25",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07449039",
"publication_url": "https://clinicaltrials.gov/study/NCT07449039",
"title": "Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial",
"has_exemption": false,
"start_date": "2025-09-28",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07010146",
"publication_url": "https://clinicaltrials.gov/study/NCT07010146",
"title": "Role of Estrogen Formulation and Route of Delivery on Skeletal Outcomes in Functional Hypothalmic Amenorrhea",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07173751",
"publication_url": "https://clinicaltrials.gov/study/NCT07173751",
"title": "A Phase III, Multisite, Randomized, Double-Blind Trial of BNT327 in Combination With Chemotherapy Versus Placebo With Chemotherapy in Patients With Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC Determined Ineligible for PD(L)1 Therapy Based on PD-L1 Negative Disease",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07454356",
"publication_url": "https://clinicaltrials.gov/study/NCT07454356",
"title": "Comparing High Intensity Stretch Device Combined With Physical Therapy Versus Physical Therapy Alone to Prevent Motion-Restoring Surgery Following Primary Total Knee Arthroplasty: Study Protocol for a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-12-09",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ermi LLC",
"sponsor_slug": "ermi-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07283367",
"publication_url": "https://clinicaltrials.gov/study/NCT07283367",
"title": "A Phase Ib/II Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HS-20110 Combination Therapies in Patients With Advanced Colorectal Cancer.",
"has_exemption": false,
"start_date": "2025-12-22",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hansoh BioMedical R&D Company",
"sponsor_slug": "hansoh-biomedical-rd-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07721415",
"publication_url": "https://clinicaltrials.gov/study/NCT07721415",
"title": "Effect of Iodine Impregnated Drapes on the Rate of Positive Cultures in Primary Total Shoulder Arthroplasty - a Prospective, Randomized Study",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "tnicholson",
"sponsor_slug": "tnicholson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07188558",
"publication_url": "https://clinicaltrials.gov/study/NCT07188558",
"title": "A Phase 3 Randomized Controlled Trial of Rondecabtagene Autoleucel , an Autologous, Dual-targeting CD19/CD20 CAR T-Cell Product Candidate, Vs. Investigator's Choice of CD19 CAR T-Cell Therapy in Patients With Relapsed or Refractory Large B-Cell Lymphoma in the Second-line Setting",
"has_exemption": false,
"start_date": "2026-01-12",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lyell Immunopharma, Inc.",
"sponsor_slug": "lyell-immunopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07258771",
"publication_url": "https://clinicaltrials.gov/study/NCT07258771",
"title": "Acute Severe Ulcerative Colitis- Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction While Transitioning Away From the Emergency Setting (ACUTE): A Phase IV, Single Center, Partially Blinded, Randomized Study",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Berinstein, Jeffrey",
"sponsor_slug": "berinstein-jeffrey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07060638",
"publication_url": "https://clinicaltrials.gov/study/NCT07060638",
"title": "Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial",
"has_exemption": false,
"start_date": "2026-01-27",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Samer Gawrieh",
"sponsor_slug": "samer-gawrieh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07380256",
"publication_url": "https://clinicaltrials.gov/study/NCT07380256",
"title": "Effects of Impaired Visual Acuity and Binocular Control Abnormalities (VABC) on Vestibulo-ocular Reflex (VOR) Adaptation in Adults With and Without Vestibular Hypofunction",
"has_exemption": false,
"start_date": "2026-02-04",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06681220",
"publication_url": "https://clinicaltrials.gov/study/NCT06681220",
"title": "Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC",
"has_exemption": false,
"start_date": "2026-02-23",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07497178",
"publication_url": "https://clinicaltrials.gov/study/NCT07497178",
"title": "A Prospective Cohort Study of High Intensity Focused Ultrasound Ablation for Brain Lesions in Children With Drug Resistant Epilepsy",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Hospital for Sick Children",
"sponsor_slug": "the-hospital-for-sick-children",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07560631",
"publication_url": "https://clinicaltrials.gov/study/NCT07560631",
"title": "SeeMe: A Multimodal Behavioral-Electrophysiological Tool for Real-Time Detection of Motor Behavior in Brain Injury Patients",
"has_exemption": false,
"start_date": "2026-03-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112196",
"publication_url": "https://clinicaltrials.gov/study/NCT07112196",
"title": "Adaptive, Phase 2/3, Randomized, Double-Blind Trial Investigating the Efficacy and Safety of Visugromab Versus Placebo in Patients With Cancer-associated Cachexia",
"has_exemption": false,
"start_date": "2026-04-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CatalYm GmbH",
"sponsor_slug": "catalym-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07439094",
"publication_url": "https://clinicaltrials.gov/study/NCT07439094",
"title": "A First-in-Human, Multicenter, Open-Label, Phase 1/2a Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CKD-703 in Advanced c-Met Expressing Solid Tumors, and in MET Amplified and c-Met Overexpressing Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-04-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Chong Kun Dang Pharmaceutical",
"sponsor_slug": "chong-kun-dang-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07162480",
"publication_url": "https://clinicaltrials.gov/study/NCT07162480",
"title": "Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)",
"has_exemption": false,
"start_date": "2026-04-29",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112105",
"publication_url": "https://clinicaltrials.gov/study/NCT07112105",
"title": "Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07394036",
"publication_url": "https://clinicaltrials.gov/study/NCT07394036",
"title": "The Effect of Ipratropium Bromide on Exercise-Induced Laryngeal Obstruction (EILO) in Pediatric Patients",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cook Children's Health Care System",
"sponsor_slug": "cook-childrens-health-care-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07613294",
"publication_url": "https://clinicaltrials.gov/study/NCT07613294",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Lepodisiran to Investigate the Effect on Coronary Plaque in Adults With Elevated Lp(a) Who Have Established Atherosclerotic Cardiovascular Disease or Are at Risk for a First Cardiovascular Event",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07556718",
"publication_url": "https://clinicaltrials.gov/study/NCT07556718",
"title": "Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease: A Multicenter Randomized Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}